In case one still isn’t convinced of the entire lack of safety regarding COVID-19 “vaccines”, an Israeli study by Christopher L.F. Sun et al titled “Increased emergency cardiovascular events among under‑40 population in Israel during vaccine rollout and third COVID‑19 wave” has found increased cases of cardiac arrest (CA) and acute coronary syndrome (ACS) since vaccination, including some parallel to vaccine rollout.
The study period starts from January 2019 to June 2021, thereby covering a “normal period”, the “pandemic period” and the “pandemic and vaccination period”.
The main finding of this study concerns with increases of over 25% in both the number of CA calls and ACS calls of people in the 16–39 age group during the COVID-19 vaccination rollout in Israel (January–May, 2021), compared with the same period of time in prior years (2019 and 2020), as shown in Table 1. Moreover, there is a robust and statistically significant association between the weekly CA and ACS call counts, and the rates of 1st and 2nd vaccine doses administered to this age group. At the same time there is no observed statistically significant association between COVID-19 infection rates and the CA and ACS call counts.
This is interesting in a disturbing way because another study by Øystein Karlstad et al titled “SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents” concluded the following:
In this cohort study of 23.1 million Nordic residents aged 12 years or older, the risk of myocarditis was higher within 28 days of vaccination with both BNT162b2 and mRNA-1273 compared with being unvaccinated, and higher after the second dose of vaccine than the first dose. The risk was more pronounced after the second dose of mRNA-1273 than after the second dose of BNT162b2, and the risk was highest among males aged 16 to 24 years. Our data are compatible with 4 to 7 excess events within 28 days per 100,000 vaccinees after a second dose of BNT162b2, and 9 to 28 excess events within 28 days per 100,000 vaccinees after a second dose of mRNA-1273. The risk of myocarditis associated with vaccination against SARS-CoV-2 must be balanced against the benefits of these vaccines.
Of course, correlation is not necessarily cause. But setting aside safety is another study that shows the entire lack of efficacy.
A Danish study by Ria Lassaunière et al titled “Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine” has found that neutralizing antibodies decline rapidly within weeks of dose 2 and dose 3. The sample size is not huge but the findings nonetheless support those of other studies thus far.
Add that to the possibility that the so-called vaccine can rewrite your genes 6 hours after administration amongst other things… well, it’s all good.
But not to worry, according to David N. Fisman et al who wrote a little paper titled “Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission”, vaccinations should still be pushed.
Although the writers admit that vaccine-induced immunity is “imperfect” (and can never be anyway), they assume more vaccines is the only solution because…? Whether one agrees with the modelling or not is irrelevant, the rhetoric is so bad that it’s not even funny.
Using simple mathematical modelling, we have shown that, although risk associated with avoiding vaccination during a virulent pandemic accrues chiefly to those who are unvaccinated, the choice of some individuals to refuse vaccination is likely to affect the health and safety of vaccinated people in a manner disproportionate to the fraction of unvaccinated people in the population.
Translation: Whether directly or indirectly, it’s all the unvaccinated people’s fault if the vaccinated have problems so unvaccinated people are selfish jerks who should get vaccinated.
Oh, and by the way, as of 6 May 2022 in the US…
579.64 million doses administered with 1,261,149 adverse events reported:
~217.6 adverse events per 100,000 doses, or 1 adverse event per 460 doses.
Also, there are 27,968 deaths reported, approximately 2.22% of reported adverse events.
The reports can be called up at vaers.hhs.gov/data.html and medalerts.org/vaersdb/index.php. There is some variation in the figures between the two platforms. The screenshot is from the latter.
Be sure to subscribe to our mailing list so you get each new Opinyun that comes out!
